About the Authors
- Sajni Josson
-
Contributed equally to this work with: Sajni Josson, Yasuhiro Matsuoka, Murali Gururajan
* E-mail: Sajni.Josson@cshs.org (SJ); Leland.Chung@cshs.org (LC)
Affiliation Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
- Yasuhiro Matsuoka
-
Contributed equally to this work with: Sajni Josson, Yasuhiro Matsuoka, Murali Gururajan
Affiliation Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
- Murali Gururajan
-
Contributed equally to this work with: Sajni Josson, Yasuhiro Matsuoka, Murali Gururajan
Affiliation Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
- Takeo Nomura
-
Affiliation Molecular Urology and Therapeutics, Emory University School of Medicine, Atlanta, Georgia United States of America
- Wen-Chin Huang
-
Affiliation Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
- Xiaojian Yang
-
Affiliation Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
- Jin-tai Lin
-
Affiliation Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
- Roger Bridgman
-
Affiliation Hybridoma Facility, Auburn University, Auburn, Alabama, United States of America
- Chia-Yi Chu
-
Affiliation Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
- Peter A. Johnstone
-
Affiliation Radiation Oncology, Indiana University School of Medicine, Bloomington, Indiana, United States of America
- Majd Zayzafoon
-
Affiliation Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Peizhen Hu
-
Affiliation Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
- Haiyen Zhau
-
Affiliation Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
- Dror Berel
-
Affiliation Biostatistics and Bioinformatics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
- Andre Rogatko
-
Affiliation Biostatistics and Bioinformatics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
- Leland W. K. Chung
-
* E-mail: Sajni.Josson@cshs.org (SJ); Leland.Chung@cshs.org (LC)
Affiliation Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: SJ LWC. Performed the experiments: SJ YM MG TN WCH XY JTL CYC MZ PH HZ. Analyzed the data: SJ YM MG DB AR LWC. Contributed reagents/materials/analysis tools: RB PAJ. Wrote the paper: SJ MG LWC.